Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Adiponectin is an independent predictor of tissue plasminogen activator levels in patients under haemodialysis.

do Sameiro Faria M, Ribeiro S, Nascimento H, Rocha-Pereira P, Miranda V, Mendonça D, Quintanilha A, Costa E, Belo L, Santos-Silva A.

Scand J Urol Nephrol. 2012 Dec;46(6):461-5. doi: 10.3109/00365599.2012.708943. Epub 2012 Aug 2.

PMID:
22852746
2.

Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.

Tomura S, Nakamura Y, Doi M, Ando R, Ida T, Chida Y, Ootsuka S, Shinoda T, Yanagi H, Tsuchiya S, Marumo F.

Am J Kidney Dis. 1996 Jun;27(6):848-54.

PMID:
8651250
3.

Vascular access versus the effect of statins on inflammation and fibrinolysis in renal dialysis patients.

do Sameiro Faria M, Ribeiro S, Rocha-Pereira P, Miranda V, Quintanilha A, Reis F, Costa E, Belo L, Santos-Silva A.

J Vasc Access. 2013 Oct-Dec;14(4):335-41. doi: 10.5301/jva.5000132. Epub 2013 May 3.

PMID:
23661140
4.

Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.

Peng Y, Liu H, Liu F, Ouyang L, Cheng M, Gao L, Pan F, Liu Y, Chen X, Li J.

Nephrology (Carlton). 2008 Oct;13(7):579-86. doi: 10.1111/j.1440-1797.2008.00987.x.

PMID:
19161364
5.

Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.

Wållberg-Jonsson S, Cvetkovic JT, Sundqvist KG, Lefvert AK, Rantapää-Dahlqvist S.

J Rheumatol. 2002 May;29(5):875-82.

PMID:
12022343
6.

Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.

Mertens I, Ballaux D, Funahashi T, Matsuzawa Y, Van der Planken M, Verrijken A, Ruige JB, Van Gaal LF.

Thromb Haemost. 2005 Dec;94(6):1190-5.

PMID:
16411393
7.

Cross-talk between inflammation,coagulation/fibrinolysis and vascular access in hemodialysis patients.

Costa E, Rocha S, Rocha-Pereira P, Castro E, Reis F, Teixeira F, Miranda V, Do Sameiro Faria M, Loureiro A, Quintanilha A, Belo L, Santos-Silva A.

J Vasc Access. 2008 Oct-Dec;9(4):248-53.

PMID:
19085894
8.

Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis.

Segarra A, Chacón P, Martinez-Eyarre C, Argelaguer X, Vila J, Ruiz P, Fort J, Bartolomé J, Camps J, Moliner E, Pelegrí A, Marco F, Olmos A, Piera L.

J Am Soc Nephrol. 2001 Jun;12(6):1255-63.

PMID:
11373350
9.

Factors affecting fibrinolytic potential: cardiovascular fitness, body composition, and lipoprotein(a).

Szymanski LM, Durstine JL, Davis PG, Dowda M, Pate RR.

Metabolism. 1996 Nov;45(11):1427-33.

PMID:
8931650
10.

Fibrinolytic activity in peripheral atherosclerosis in the elderly.

van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C.

Thromb Haemost. 1999 Feb;81(2):275-80.

PMID:
10064006
11.

Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells.

Kugiyama K, Sakamoto T, Misumi I, Sugiyama S, Ohgushi M, Ogawa H, Horiguchi M, Yasue H.

Circ Res. 1993 Aug;73(2):335-43.

PMID:
8330376
12.

Main determinants of PON1 activity in hemodialysis patients.

Ribeiro S, do Sameiro Faria M, Mascarenhas-Melo F, Freitas I, Mendonça MI, Nascimento H, Rocha-Pereira P, Miranda V, Mendonça D, Quintanilha A, Belo L, Costa E, Reis F, Santos-Silva A.

Am J Nephrol. 2012;36(4):317-23. doi: 10.1159/000342235. Epub 2012 Sep 22.

PMID:
23007074
13.

Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.

Goicoechea M, de Vinuesa SG, Lahera V, Cachofeiro V, Gómez-Campderá F, Vega A, Abad S, Luño J.

J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S231-5.

PMID:
17130267
14.

Hemostatic variables, carbohydrate metabolism and lipid profile in women with low body mass index.

Polac I, Stachowiak G, Jedrzejczyk S, Stetkiewics T, Sobieszczanska S, Pertynski T.

Gynecol Endocrinol. 2003 Apr;17(2):151-7.

PMID:
12744226
15.

Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients.

Warshofsky MK, Wasserman HS, Wang W, Teng P, Sciacca R, Apfelbaum M, Schwartz A, Michler RE, Mancini DM, Cannon PJ, Rabbani LE.

Am J Cardiol. 1997 Jul 15;80(2):145-9.

PMID:
9230149
16.

Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traits.

Asselbergs FW, Williams SM, Hebert PR, Coffey CS, Hillege HL, Navis G, Vaughan DE, van Gilst WH, Moore JH.

J Thromb Haemost. 2007 Feb;5(2):313-20. Epub 2006 Nov 9.

PMID:
17092303
17.

Decreased high-density lipoprotein cholesterol is associated with inflammation and insulin resistance in non-diabetic haemodialysis patients.

Peng YS, Chiu YL, Chen HY, Yang JY, Lai CF, Hsu SP, Pai MF.

Nephrology (Carlton). 2010 Oct;15(7):692-9. doi: 10.1111/j.1440-1797.2010.01295.x.

PMID:
21040164
18.

Oxidized low-density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene.

Ribeiro S, Faria Mdo S, Silva G, Nascimento H, Rocha-Pereira P, Miranda V, Vieira E, Santos R, Mendonça D, Quintanilha A, Costa E, Belo L, Santos-Silva A.

Hemodial Int. 2012 Oct;16(4):481-90. doi: 10.1111/j.1542-4758.2012.00687.x. Epub 2012 Apr 20.

PMID:
22515595
19.

Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.

Akanji AO, Abdullah A, Tahzeeb S.

Eur J Clin Invest. 1997 May;27(5):380-6.

PMID:
9179544
20.

Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.

DeSouza CA, Jones PP, Seals DR.

Arterioscler Thromb Vasc Biol. 1998 Mar;18(3):362-8.

PMID:
9514404

Supplemental Content

Support Center